BioWorld MedTech

Jan. 25, 2011

Deals roundup: Novartis to acquire Genoptix for nearly $470 million

Shares of Genoptix (Carlsbad, California) saw unusually high trading volume Monday, after Novartis (Basel, Switzerland) reported that it would acquire the company for $470 million. (Medical Device Daily) Read More

Midwest attracts $737M in new investments in 2010

Report from Europe: European Union seen driving bio-medical imaging network

Washington roundup: Alphatec hit with warning over 522 surveillance study

Financings roundup: Digital Assent reports closing $2M Series A funding round

Coming Wednesday in MDD Perspectives: Revenue at risk as non-qualifying patients receive med-tech products

HIT roundup: Merge Healthcare deploys iConnect Access at UHMC

People in the News

Med-Tech Notes

Patent watch: Biolase issued new patent for presbyopia/hyperopia

Agreements/contracts: KOL clients expand with Heartbeat Express

Product Briefs

MDD's Cardio Extra

Today's news in brief

BioWorld

BioWorld briefs for May 21, 2026.

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

News in brief

BioWorld Asia

BioWorld Asia briefs for May 19, 2026

WHO declares Ebola outbreak a public health emergency of international concern

BioWorld

The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...

Nxera Pharma prepares and tests new GPR17 antagonists

BioWorld Science

Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...